首页|喜炎平注射液辅治呼吸机相关性肺炎临床观察

喜炎平注射液辅治呼吸机相关性肺炎临床观察

扫码查看
目的:观察喜炎平注射液辅治重症监护室(ICU)呼吸机相关性肺炎(VAP)的疗效。方法:64例按随机数字表法分为两组各32例。两组均行纤维支气管镜治疗,观察组加用喜炎平注射液治疗。结果:总有效率观察组高于对照组(P<0。05)。治疗后观察组白细胞计数(WBC)、C反应蛋白(CRP)、降钙素原(PCT)、白介素-6(IL-6)水平及临床肺部感染评分(CPIS)均低于对照组(P<0。05)。两组不良反应发生率比较差异无统计学意义(P>0。05)。结论:喜炎平注射液辅治VAP疗效较好,且安全。
Objective:To observe the efficacy of Xiyanping Injection in the treatment of ventilator-associated pneumonia(VAP)in intensive care unit(ICU).Methods:Sixty-four cases were randomly divided into two groups,32 cases in each group.Both groups were treated with fiberoptic bronchoscopy,and the observation group was treated with Xiyanping injection.Results:The total effective rate of the observation group was higher than that of the control group(P<0.05).After treatment,the levels of white blood cell count(WBC),C-reactive protein(CRP),procalcitonin(PCT),interleukin-6(IL-6)and clinical pulmonary infection score(CPIS)in the observation group were lower than those in the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Xiyanping injection is effective and safe in the treatment of VAP.

Ventilator-associated pneumoniaXiyanping InjectionControl treatment and observation

黎泉交、张文贵、刘君

展开 >

江西省兴国县中医院住院部东区三楼重症医学科,江西 兴国 342400

呼吸机相关性肺炎 喜炎平注射液 对照治疗观察

2024

实用中医药杂志
重庆医科大学中医药学院

实用中医药杂志

影响因子:0.546
ISSN:1004-2814
年,卷(期):2024.40(7)